Roh YS, Choi J, Sutaria N, et al. Itch: Epidemiology, clinical
presentation, and diagnostic workup. J Am Acad Dermatol.
2022;86(1):1–14.
Ständer S, Schäfer I, Phan NQ, et al. Prevalence of chronic
pruritus in Germany: results of a cross-sectional study in a
Kini SP, DeLong LK, Veledar E, et al. The impact of pruritus on
quality of life: the skin equivalent of pain. Arch Dermatol. 2011;
147(10):1153–1156.
Legat FJ, Weisshaar E, Fleischer AB, et al. Prurito y disestesia.
En: Bolognia JL, Schaffer J, Cerroni L, editores. Dermatología.
4a ed. Barcelona,...
Zeidler C, Pereira MP, Huet F, et al. Pruritus in autoimmune
and inflammatory dermatoses. Front Immunol. 2019;10:1303.
Huet F, Faffa MS, Poizeau F, et al. Characteristics of pruritus in
relation to self-assessed severity of atopic dermatitis. Acta
Derm Venereol....
Sher LG, Chang J, Patel IB, et al. Relieving the pruritus of atopic
dermatitis: a meta-analysis. Acta Derm Venereol. 2012;92(5):
455–461.
Weidinger S, Novak N. Atopic dermatitis. Lancet 2016;387
(10023):1109–1122.
Yosipovitch G, Berger T, Fassett MS. Neuroimmune interactions in chronic itch of atopic dermatitis. J Eur Acad Dermatol
Venereol. 2020;34(2):239–250.
Lu J, Wu K, Zeng Q, et al. Serum interleukin-31 level and
pruritus in atopic dermatitis: a Meta-analysis. Zhong Nan Da
Xue Xue Bao Yi Xue...
Szepietowski JC, Reich A. Pruritus in psoriasis: an update. Eur J
Pain. 2016;20(1):41–46.
Yosipovitch G, Goon A, Wee J, et al. The prevalence and
clinical characteristics of pruritus among patients with
extensive psoriasis. Br J...
Jaworecka K, Muda-Urban J, Rzepko M, et al. Molecular aspects
of pruritus pathogenesis in psoriasis. Int J Mol Sci. 2021;22(2):
858.
Nakamura M, Toyoda M, Morohashi M. Pruritogenic mediators
in psoriasis vulgaris: comparative evaluation of itch-associated cutaneous factors....
Taneda K, Tominaga M, Negi O, et al. Evaluation of epidermal
nerve density and opioid receptor levels in psoriatic itch. Br J
Dermatol. 2011;165(2):277–284.
Pariser DM, Bagel J, Lebwohl M, et al. Serlopitant for psoriatic
pruritus: a phase 2 randomized, double-blind, placebo-controlled clinical...
Roblin D, Yosipovitch G, Boyce B, et al. Topical TrkA kinase
inhibitor CT327 is an effective, novel therapy for the treatment of pruritus...
van Beek N, Zillikens D, Schmidt E. Diagnosis of autoimmune
bullous diseases. J Dtsch Dermatol Ges. 2018;16(9):1077–1091.
Ben Mordehai Y, Faibish H, Astman N, et al. Characteristics of
patients with bullous pemphigoid: comparison of classic
bullous pemphigoid...
Montagnon CM, Tolkachjov SN, Murrell DF, et al. Subepithelial
autoimmune blistering dermatoses: clinical features and
diagnosis. J Am Acad...
Briand C, Gourier G, Poizeau F, et al. Characteristics of pruritus
in bullous pemphigoid and impact on quality of life: a
prospective cohort...
Sun C, Feng S. Recent developments in the pathogenesis of
pruritus in bullous pemphigoid. Int J Dermatol. 2021;60(12):
1441–1448.
Hashimoto T, Kursewicz CD, Fayne RA, et al. Pathophysiologic
mechanisms of itch in bullous pemphigoid. J Am Acad
Dermatol. 2020;83(1):53–62.
Yang J, Gao H, Zhang Z, et al. Dupilumab combined with lowdose systemic steroid therapy improves efficacy and safety for
bullous pemphigoid....
Kulczycka-Siennicka L, Cynkier A, Waszczykowska E, et al.
The role of Intereukin-31 in pathogenesis of itch and its
intensity in a course...
Bonciani D, Quintarelli L, Del Bianco E, et al. Serum levels and
tissue expression of interleukin-31 in dermatitis
herpetiformis and bullous...
Xia Q, Liu T, Wang J, et al. Mast cells and thymic stromal
lymphopoietin (TSLP) expression positively correlates with
pruritus intensity in...
Rolader R, Daugherty LN, Liu Y, et al. Prevalence and
predictors of pruritus in pemphigus compared with bullous
pemphigoid: a cross-sectional...
Yu X, Kasprick A, Hartmann K, et al. The role of mast cells in
autoimmune bullous dermatoses. Front Immunol. 2018;9:386.
Morais KL, Miyamoto D, Orfali RL, et al. Increased expression
of in situ IL-31RA and circulating CXCL8 and CCL2 in
pemphigus herpetiformis...
Yahya A, Gideon PS. Characterizing pruritus in autoimmune
connective tissue diseases. J Drugs Dermatol. 2019;18(10):
995–998.
Pathania YS. An overview of pruritus in autoimmune connective tissue diseases. Int J Dermatol. 2022;61(5):515–518.
Samotij D, Szczęch J, Antiga E, et al. Clinical characteristics of
itch in cutaneous lupus erythematosus: a prospective, multicenter, multinational,...
Wong LS, Yen YT. Autoimmune connective tissue diseasesrelated pruritus: proper diagnosis and possible mechanisms.
Diagnostics (Basel). 2022;12(7):1772.
Lauinger J, Ghoreschi K, Volc S. Characteristics of dermatomyositis patients with and without associated malignancy. J
Dtsch Dermatol Ges....
Razykov I, Levis B, Hudson M, Canadian Scleroderma Research
Group, et al. Prevalence and clinical correlates of pruritus in
patients with...
Gourier G, Théréné C, Mazeas M, et al. Clinical characteristics
of pruritus in systemic sclerosis vary according to the
autoimmune subtype....
